Source:http://linkedlifedata.com/resource/pubmed/id/19396160
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-5-11
|
pubmed:abstractText |
We show that selection of drug-resistant bacterial mutants allows the discovery of antibacterial compounds. Mutant strains of a soil-isolated Streptomyces species that does not produce antibacterials synthesize a previously unknown class of antibacterial, which we name piperidamycin. Overall, 6% of non-Streptomyces actinomycetes species and 43% of Streptomyces species that do not produce antibacterials are activated to produce them. The antibacterial-producing mutants all carried mutations in RNA polymerase and/or the ribosomal protein S12.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1546-1696
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
462-4
|
pubmed:meshHeading |
pubmed-meshheading:19396160-Actinobacteria,
pubmed-meshheading:19396160-Anti-Bacterial Agents,
pubmed-meshheading:19396160-DNA-Directed RNA Polymerases,
pubmed-meshheading:19396160-Drug Discovery,
pubmed-meshheading:19396160-Mutation,
pubmed-meshheading:19396160-Ribosomal Proteins,
pubmed-meshheading:19396160-Streptomyces
|
pubmed:year |
2009
|
pubmed:articleTitle |
Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12.
|
pubmed:affiliation |
National Food Research Institute, Tsukuba, Ibaraki, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|